This support the hypothesis that AFP-positive HCC cells have stronger interactions with ECs, and that inhibiting VEGFR2-positive ECs disrupts this interaction.These findings also suggest a crucial role for ECs in the TME in supporting the survival of CSCs. The gene discussed is AFP; the disease is hepatocellular carcinoma.